The global sleep aids market is likely to register a CAGR of over 6.6% with an incremental growth of USD 40 billion during the forecast period 2022-2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global sleep aids market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the sleep aids industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, sleep disorder, and region. The global market for sleep aids can be segmented by product: mattress & pillows, sleep laboratories, medications, sleep apnea devices, others. Among these, the mattress & pillows segment was accounted for the highest revenue generator in 2021. Sleep aids market is further segmented by sleep disorder: insomnia, narcolepsy, restless legs syndrome (RLS), sleep apnea, others. The insomnia segment is estimated to account for the largest share of the global sleep aids market. Based on region, the sleep aids market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America held the largest share of the global sleep aids market in 2021 and is anticipated to hold its share during the forecast period.
By product:
- mattress & pillows
- sleep laboratories
- medications
- sleep apnea devices
- others
By sleep disorder:
- insomnia
- narcolepsy
- restless legs syndrome (RLS)
- sleep apnea
- others
By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
The market research report covers the analysis of key stake holders of the global sleep aids market. Some of the leading players profiled in the report include Advanced Brain Monitoring, Inc., Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Laboratories, Inc., Fisher & Paykel Healthcare Corporation Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Pfizer, Inc, ResMed Inc., Sanofi S.A., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global sleep aids market.
- To classify and forecast the global sleep aids market based on product, sleep disorder, region.
- To identify drivers and challenges for the global sleep aids market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global sleep aids market.
- To identify and analyze the profile of leading players operating in the global sleep aids market.
Why Choose This Report
- Gain a reliable outlook of the global sleep aids market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· Mattress & pillows
· Sleep laboratories
· Medications
· Sleep apnea devices
· Others
PART 6. MARKET BREAKDOWN BY SLEEP DISORDER
· Insomnia
· Narcolepsy
· Restless legs syndrome (RLS)
· Sleep apnea
· Others
PART 7. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 8. KEY COMPANIES
· Advanced Brain Monitoring, Inc.
· Apnea Sciences Corporation
· Boehringer Ingelheim International GmbH
· Cadwell Laboratories, Inc.
· Fisher & Paykel Healthcare Corporation Limited
· Natus Medical Incorporated
· Nihon Kohden Corporation
· Pfizer, Inc
· ResMed Inc.
· Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
The Sleep Service Provider Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturer...
This report gives an insight into the global Sleep Apnea Oral Appliances Market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2023-2030. The future growth has been calculated by taking into account the present growth rate and the overall ...
Overview of the Global Sleep Therapy Sound Apps Market:
The report discusses everything a marketer requires before investing in the global Sleep Therapy Sound Apps Market during the forecast period 2023-2030. It pro...
Overview of the Global Sleep Health Technology Solutions Market:
The report discusses everything a marketer requires before investing in the global Sleep Health Technology Solutions Market during the forecast period...
Overview of the Global Sleep Disorder Management Software Market:
The report discusses everything a marketer requires before investing in the global Sleep Disorder Management Software Market during the forecast peri...
Overview of the Global Sleep Medicine EMR (Electronic Medical Records) Market:
The report discusses everything a marketer requires before investing in the global Sleep Medicine EMR (Electronic Medical Records) Marke...
Overview of the Global Home Sleep Apnea Machine Market:
The report discusses everything a marketer requires before investing in the global Home Sleep Apnea Machine Market during the forecast period 2023-2030. It pro...
Asia Pacific medical device market will grow by 8.4% annually with a total addressable market cap of $2.06 trillion over 2023-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insura...
Europe medical device market was valued at $144.4 billion in 2022 and will grow by 4.7% annually over 2022-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insurance.
Highlig...
North America medical device market is projected to grow by 3.9% annually in the forecast period and reach $ 282.3 billion by 2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insura...